Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$283,897
+$59,711 QoQ
Shares Held
306
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#354
of 504 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantum Portfolio Management LLC holds $1,425,090 across 6 Biotechnology names. ARGX ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
807 | $400,861 | |
| 2 | ARGX |
Argenx SE
This page
|
306 | $283,897 | |
| 3 | BNTX |
BioNTech SE
|
2,766 | $257,376 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
14,343 | $255,592 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,093 | $113,880 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
182 | $113,484 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,897 | 306 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $224,186 | 307 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $518,866 | 617 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $691,093 | 937 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $642,171 | 1,165 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,271,326 | 2,148 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||